Newark, DENCT07228000Now EnrollingIRB Ready

Breast Cancer Screening Clinical Trial in Newark, DE

Access cutting-edge breast cancer screening treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.

Sponsored by Georgetown University

Quick Self-Assessment

See if you qualify for this Newark location

Preparing your pre-screening questions…

Expert Care in Newark

Access breast cancer screening specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer screening treatment provided free

Apply for This Newark Location

Check if you qualify for this breast cancer screening clinical trial in Newark, DE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Newark

    Convenient for DE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Newark site if eligible
  4. 4Begin participation

About This Breast Cancer Screening Study in Newark

The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.

Sponsor: Georgetown University

Who Can Participate

Inclusion Criteria

Seeking screening navigation services through programs at a participating site (Georgetown Lombardi Cancer Center or Helen F. Graham Cancer Center \& Research Institutes)
Eligible for breast cancer screening while also due and eligible for colorectal cancer screening (per USPSTF guidelines)
Identify as Black/African American race and/or Hispanic/Latin(e)(a) ethnicity
Speak English or Spanish with enough fluency to complete study activities
Stated willingness to comply with all study procedures (navigation, surveys) and availability for the duration of the study
Provision of completed electronic informed consent form

Exclusion Criteria

Not engaged with or planning to use navigation programs at Georgetown Lombardi Cancer Center and Helen F. Graham Cancer Center \& Research Institute
Not eligible for breast cancer screening or not due and eligible for colorectal cancer screening (per USPSTF guidelines)
History of breast and/or colorectal cancer; or Reporting symptoms related to breast and/or colorectal cancer (e.g., GI bleeding, breast mass)
Male sex, Intersex, or other sex
Under age 45 or over age 74
Identifies as neither Black/African American race nor Hispanic/Latin(e)(a) ethnicity
Speaks neither English nor Spanish with enough fluency to complete study activities
Stated unwillingness to comply with study procedures (navigation, surveys) or unavailability for the duration of the study
Inability to provide electronic informed consent, or needing another person to authorize informed consent on their behalf

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Newark?

Yes, this clinical trial (NCT07228000) has an active research site in Newark, DE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Screening Treatment Options in Newark, DE

If you're searching for breast cancer screening treatment options in Newark, DE, this clinical trial (NCT07228000) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer screening specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer screening clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Newark, DE

See all breast cancer clinical trials recruiting in Newark — not just this study.

Browse Breast Cancer Trials in Newark →

Browse More Trials by Condition

Breast Cancer TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Newark?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Newark, DE